A R T I C L E S
Trost et al.
(d, J ) 8.3 Hz, 2H), 6.31 (d, J ) 11.8 Hz, 1H), 5.65 (app q, J ) 2.5
Hz, 1H), 4.61 (dd, J ) 2.5, 18.5 Hz, 1H), 4.46 (dd, J ) 9.2, 11.8 Hz,
1H), 4.18 (br d, J ) 18.5 Hz, 1H), 3.71 (s, 3H), 2.86 (tt, J ) 2.2, 9.2
Hz, 1H), 2.78 (qd, J ) 5.8, 9.2 Hz, 1H), 2.45 (9s, 3H), 1.48 (d, J )
5.8 Hz, 3H), 0.93 (s, 9H), 0.16 (s, 6H). 13C NMR (125 MHz, CDCl3)
((E)-enol silane): δ 166.2, 159.8, 145.1, 143.7, 132.4, 129.7 (2), 127.9
(2), 113.2, 107.0, 60.4, 53.6, 52.9, 51.3, 25.5 (3), 21.5, 19.0, 18.2,
-5.29, -5.33.
raphy, eluting with 1:9 petroleum ether-diethyl ether, to give the
1
intermediate aldehyde. IR (neat): 2924, 1722, 1450, 1162 cm-1. H
NMR (300 MHz, CDCl3): δ 9.68 (s, 1H), 7.62 (d, J ) 8.3 Hz, 2H),
7.26 (d, J ) 8.3 Hz, 2H), 4.87 (s, 1H), 4.83 (s, 1H), 4.06 (dq, J ) 6.6,
17.3 Hz, 1H), 3.77 (ddd, J ) 5.8, 12.2, 22.2 Hz, 1H), 2.94 (dd, J )
7.5, 17.3 Hz, 1H), 2.84 (td, J ) 3.4, 12.4 Hz, 1H), 2.66 (m, 1H), 2.56
(ddd, J ) 1, 5.5, 22.2 Hz, 1H), 2.39 (s, 3H), 2.39 (m overlapped, 1H),
2.12 (br d, J ) 13.9 Hz, 1H), 0.84 (d, J ) 6.9 Hz, 3H). 13C NMR (75
MHz, CDCl3): δ 201.8, 143.3, 141.2, 137.3, 129.7 (2), 126.7 (2), 113.8,
52.7, 445.6, 42.7, 40.2, 30.4, 21.4, 14.7.
Data for 53. IR (neat): 2930, 1715, 1654, 1358, 1166 cm-1. 1H NMR
(500 MHz, CDCl3): δ 7.73 (d, J ) 8.3 Hz, 2H), 7.33 (d, J ) 8.3 Hz,
2H), 6.40 (d, J ) 5.6 Hz, 1H), 5.63 (q, J ) 2.5 Hz, 1H), 4.62 (dd, J
) 1.9, 18.5 Hz, 1H), 4.19 (dt, J ) 2.5, 18.5 Hz, 1H), 4.03 (dd, J )
5.6, 8.7 Hz, 1H), 3.69 (s, 3H), 3.67 (br t partially overlapped, J ) 8.7
Hz, 1H), 2.86 (qd, J ) 6.1, 9.0 Hz, 1H), 2.43 (s, 3H), 1.46 (d, J ) 6.1
Hz, 3H), 0.90 (s, 3H), 0.13 (s, 6H). 13C NMR (125 MHz, CDCl3): δ
166.3, 159.9, 143.5, 142.8, 132.8, 129.6 (2), 127.8 (2), 112.3, 105.4,
60.7, 53.6, 51.2, 48.5, 25.4 (3), 21.5, 19.5, 18.0, -5.43, -5.48. Anal.
Calcd (as mixture) for C23H35NO5SSi: C, 59.32; H, 7.57; N, 3.00; S,
6.88. Found: C, 59.23; H, 7.47; N, 3.03; S, 6.71.
(2S,3R)-N-(4-Methylbenzenesulfonyl)-2-methyl-3-[2-hydroxyethyl]-
4-methoxycarbonylmethylenepyrrolidine (65) was obtained using the
procedure described for the obtention of derivative 40. Alcohol 65 was
then recovered in 74% yield as a colorless oil. [R]D ) +67.0 (c 2.75,
CHCl3). IR (neat): 3534, 2951, 1715, 1667, 1162 cm-1. 1H NMR (500
MHz, CDCl3): δ 7.76 (d, J ) 8.3 Hz, 2H), 7.32 (d, J ) 8.3 Hz, 2H),
5.82 (td, J ) 1.4, 2.7 Hz, 1H), 4.51 (dd, J ) 2.2, 18.3 Hz, 1H), 4.33
(ddd, J ) 2.0, 2.9, 18.3 Hz, 1H), 3.86 (dq, J ) 1.7, 6.5 Hz, 1H), 3.71
(s, 3H), 3.57 (m, 2H), 2.63 (tq, J ) 1.3, 7.3 Hz, 1H), 2.42 (s, 3H),
1.71 (br s, 1H), 1.45 (ddt, J ) 5.6, 7.0, 12.7 Hz, 1H), 1.32 (m, 1H),
1.19 (d, J ) 6.3 Hz, 3H).13C NMR (125 MHz, CDCl3): δ 166.0, 161.2,
143.4, 135.9, 129.6 (2), 127.1 (2), 1114.3, 59.7, 59.4, 51.4, 499.9, 49.4,
35.9, 21.4, 20.9. Anal. Calcd for C17H23NO5S: C, 57.77; H, 6.56; N,
3.96; S, 9.07. Found: C, 57.88; H, 6.58; N, 3.91; S, 9.27.
The latter substance was then taken up in ether (3 mL), and lithium
aluminum hydride (0.025 g, 0.66 mmol) was added. The reaction was
stirred at room temperature for 5 min. Technical Et2O (3 mL) and a
saturated solution of Na2SO4 (0.1 mL) were added. After 10 min, the
heterogeneous mixture was filtered through a pad of silica (Et2O) to
afford pure 66 (0.060 g, 0.194 mmol) as a colorless oil. [R]D ) -44.0
1
(c 2.02, CHCl3). IR (neat): 3521, 2942, 1651, 1336, 1160 cm-1. H
NMR (500 MHz, CDCl3): δ 7.68 (d, J ) 8.3 Hz, 2H), 7.29 (d, J ) 8.3
Hz, 2H), 4.89 (t, J ) 2 Hz, 1H), 4.81 (t, J ) 1.7 Hz, 1H), 4.14 (q, J
) 6.8 Hz, 1H), 3.79 (dd, J ) 6.1, 12.2 Hz, 1H), 3.68 (td, J ) 5.6, 11.0
Hz, 1H), 3.60 (td, J ) 6.6, 11.0 Hz, 1H), 2.87 (td, J ) 3.1, 12.4 Hz,
1H), 2.42 (s, 3H), 2.42 (m overlapped, 1H), 2.25 (t, J ) 7.5 Hz, 1H),
2.09 (d, J ) 13.4 Hz, 1H), 1.86 (d, J ) 6.3 Hz, 1H), 1.83 (d, J ) 6.3
Hz, 1H), 1.63 (br s, 1H), 0.87 (d, J ) 6.8 Hz, 3H). 13C NMR (125
MHz, CDCl3): δ 143.3, 142.9, 137.8, 129.6 (2), 126.8 (2), 113.0, 60.7,
53.3, 46.3, 40.5, 34.2, 30.2, 21.4, 15.0. Anal. Calcd for C16H23NO3S:
C, 62.10; H, 7.49; N, 4.52; S, 10.36. Found: C, 61.97; H, 7.26; N,
4.39; S, 10.19.
(2S,3R,4R)-N-(4-Methylbenzenesulfonyl)-2,3-dimethyl-4-(2-hy-
droxyethyl)-5-methylenepiperidine (56) was obtained starting from
alkyne 23 (75 mg, 0.2 mmol) and using procedures reported before.
56 (0.031 g, 0.096 mmol) was recovered as a colorless oil. [R]D
)
11.2 (c 1.62, CHCl3). IR (neat): 3510, 2935, 1338, 1154 cm-1. 1H NMR
(500 MHz, CDCl3): δ 7.69 (d, J ) 8.3 Hz, 2H), 7.29 (d, J ) 8.3 Hz,
2H), 5.04 (s, 1H), 4.82 (s, 1H), 3.92 (d, J ) 13.4 Hz, 1H), 3.92 (m
overlapped, 1H), 3.75 (d, J ) 13.4 Hz, 1H), 3.66 (ddd, J ) 4.8, 7.5,
10.5 Hz, 1H), 3.59 (dt, J ) 7.3, 10.5 Hz, 1H), 2.43 (s, 3H), 2.11 (br t,
J ) 9.3 Hz, 1H), 1.75 (tdd, J ) 2.9, 7.8, 13.9 Hz, 1H), 1.53 (m, 1H),
1.42 (m, 1H), 1.61 (br s, 1H), 1.12 (d, 7.1 Hz, 3H), 0.89 (d, J ) 6.8
Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 143.3, 143.0, 137.0, 129.5
(2) 127.0 (2), 111.8, 60.0, 54.0, 47.3, 38.8, 38.4, 32.3, 32.3, 21.4, 16.8,
13.1. Anal. Calcd for C17H25NO3S: C, 63.12; H, 7.79; N, 4.33; S, 9.91.
Found: C, 63.53; H, 7.39; N, 3.96; S, 9.56. HRMS: calcd for C17H25-
NO3S, [M+], 323.1555; found, 323.1551.
(2S,3R)-N-(4-Methylbenzenesulfonyl)-2-methyl-3-[(E)-2-(tert-
butyldimethylsilyloxy)vinyl]-4-methylenepiperidine (54) was ob-
tained by carrying out the typical procedure from alkyne 19b (0.085
g, 0.2 mmol). The crude product was directly chromatographed over
silica gel, eluting with 9:1 petroleum ether-ether, to afford 54 (0.082
g, 0.194 mmol) as a colorless oil. IR (neat): 2930, 1654, 1340, 1163
1
cm-1. H NMR (500 MHz, CDCl3): δ 7.66 (d, J ) 8.3 Hz, 2H), 7.24
(d, J ) 8.3 Hz, 2H), 6.29 (d, J ) 11.9 Hz, 0.8H), 6.12 (d, J ) 5.8 Hz,
0.2H), 5.14 (dd, J ) 7.6, 11.9 Hz, 0.8H), 4.76 (br s, 1H), 4.74 (m
overlapped, 0.2H), 4.71 (br s, 1H), 4.08 (q, J ) 6.6 Hz, 0.8H), 4.05 (q,
J ) 7.0 Hz, 0.2H), 3.74 (dd, J ) 5,8, 12.2 Hz, 0.2H), 3.70 (dd, J )
5.8, 12.2 Hz, 0.8H), 3.18 (br d, J ) 8.8 Hz, 0.2H), 2.86 (td, J ) 3.4,
12.4 Hz, 1H), 2.57 (d, J ) 7.5 Hz, 0.8H), 2.41 (m overlapped, 1H),
2.38 (s, 3H), 2.01 (br d, J ) 13.4 Hz, 1H), 0.89 (s, 9H), 0.11 (s, 3H),
0.10 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 144.2, 143.5, 142.88,
142.82, 141.7, 138.79, 137.9, 129.5, 129.4, 127.05, 127.02, 111.82,
111.7, 109.8, 54.6, 54.2, 48.0, 44.5, 40.71, 40.68, 30.89, 30.4, 25.65,
25.55, 21.4, 18.2, 18.1, 15.33, 15.0, -5.22, -5.4. Anal. Calcd for
C22H35NO3SSi: C, 62.66; H, 8.36; N, 3.32; S, 7.60. Found: C, 62.49;
H, 8.31; N, 3.34; S, 7.44.
Acknowledgment. We thank the National Science Foundation
and National Institutes of Health, General Medical Sciences
(Grant 13598), for their generous support of our programs. Mass
spectra were provided by the mass Spectrometry Facility,
University of San Francisco, supported by the NIH Division of
Research Resources. Dr Pierre L. Fraisse is warmly thanked
for the generous gift of catalyst 2.
(2S,3R)-N-(4-Methylbenzenesulfonyl)-2-methyl-3-(2-hydroxyethyl)-
4-methylenepiperidine (66). To a solution of silyl enol ether 54
(prepared from 0.127 g, 0.3 mmol of alkyne 19b) in CH2Cl2 (5 mL)
were added water (0.2 mL) and trifluoroacetic acid (2 mL). The reaction
was stirred at room temperature for 15 min. The volatiles were removed
under reduced pressure, and the residue was purified by chromatog-
Supporting Information Available: Experimental procedure
for compounds 6, 8a, 8b, 9a, 9b, 10, 12a, 12b, 13, 16, 19a,
19b, 21, 22, 23, 25, 26, 30a, 30b, 31, 38, 39, 40. This material
JA046824O
9
15602 J. AM. CHEM. SOC. VOL. 126, NO. 47, 2004